menu search

Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for...

October 4, 2023, 4:05 pm

Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

October 4, 2023, 4:00 pm

Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

October 4, 2023, 12:14 pm

Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...

October 4, 2023, 11:30 am

Beyond cancer™ selected to present proffered posters discussing data from the uno therapy program at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that i...

October 4, 2023, 7:30 am

Structure therapeutics: tipping the scales in obesity management

Structure Therapeutics' oral small molecule GLP-1, GSBR-1290, has shown promising results in Phase 1b s...

October 3, 2023, 11:28 pm

Chipotle is testing automation for burrito bowls, salads

Fast-casual-dining chain Chipotle is also testing out robots to help make tortillas and guacamole....

October 3, 2023, 9:06 am

Acumen pharmaceuticals: novel alzheimer's molecule with positive early data

Acumen Pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers (AβOs) in Alzheimer's disease. AβOs are smal...

October 3, 2023, 5:15 am

Angle hails the latest breast cancer study

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), the liquid biopsy and cancer diagnostics specialist, has hailed a study that could change the way doctors monitor a...

October 3, 2023, 2:46 am

The cost to borrow t2 (ttoo) stock is up 130% in just 10 days

Shares of T2 Biosystems (NASDAQ: TTOO ) are up by over 20% today on the heels of receiving U.S. Food and Drug Administration (FDA) 510(k) clearance fo...

September 29, 2023, 12:18 pm

Schrodinger: leading the ai healthcare revolution

Schrödinger is a leading AI drug discovery company with a comprehensive platform used by researchers and scientists worldwide. The company's flagship...

September 29, 2023, 3:49 am

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...

September 28, 2023, 7:18 am

Matinas biopharma to present at two investment conferences in october 2023

BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on re...

September 28, 2023, 7:00 am

Gain therapeutics to participate at cantor fitzgerald global healthcare conference 2023

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the disc...

September 25, 2023, 4:05 pm

4d molecular therapeutics: some failures, a few key successes

4D molecular Therapeutics, Inc. has faced setbacks, with the FDA placing a clinical hold on its Fabry D...

September 25, 2023, 12:19 pm

Novo nordisk announces ai collaboration with valo health for cardiometabolic treatments

Novo Nordisk (NYSE:NVO) has announced a collaboration with Valo Health to discover and develop novel treatments for cardiometabolic using Valo's artif...

September 25, 2023, 9:51 am

Matinas biopharma announces notification of nyse american continued listing deficiency

BEDMINSTER, N.J., Sept. 22, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on r...

September 22, 2023, 9:25 pm

Protagonist therapeutics: there are reasons behind johnson & johnson's optimism

Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior efficacy to Johnson & Johnson's injectable Tremfya be...

September 22, 2023, 3:35 pm

moleculin (mbrx) posts update from lung cancer study, stock up

moleculin (MBRX) completes enrollment in the phase II portion of the development program for its lead c...

September 22, 2023, 9:01 am

Brodsky & smith shareholder update: notifying investors of the following investigations: splunk, inc. (nasdaq – splk), applied molecular transport inc. (nasdaq – amti), nextgen healthcare, inc. (nasda

BALA CYNWYD, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

September 21, 2023, 8:57 pm


Search within

Pages Search Results: